So here's a bit of government hiring news that's actually interesting: the Trump administration is reportedly about to pick a new permanent director for the Centers for Disease Control and Prevention. And they're going with someone who looks, on paper at least, like a consensus builder.
According to a report published Tuesday, the expected pick is Erica Schwartz, a former deputy surgeon general and retired rear admiral. The selection is pending final approval from President Donald Trump and isn't confirmed yet, but it's the direction things are heading.
Now, why does this matter? Well, the CDC hasn't had a permanent boss since last August, when Susan Monarez was ousted. Jay Bhattacharya has been filling in as acting director since February, while also running the National Institutes of Health. That's a lot of hats for one person, and the agency has been dealing with what you might politely call 'internal challenges'—sustained turnover in senior leadership, low morale, and a general sense of instability. Oh, and there's that whole thing where the Department of Health and Human Services proposed cutting 10,000 jobs last year, including at the CDC and FDA. So yeah, the new director will have their work cut out for them.
Enter Erica Schwartz. She's a physician board-certified in preventive medicine with a master's in public health and a law degree from Brown University. She served as deputy surgeon general during Trump's first term in a nonpolitical civil service role, and she spent more than two decades in uniform, rising to rear admiral and chief medical officer of the U.S. Coast Guard. Her background emphasizes preventive medicine—things like vaccines and early detection. In a recent public message, she talked about improving health outcomes before illness even begins.
That resume is apparently seen as the kind of thing that might smooth over the Senate confirmation process and limit political friction. Health and Human Services Secretary Robert F. Kennedy Jr. and HHS Deputy Chris Klomp interviewed candidates and recommended Schwartz to the president, according to the report.
Which brings us to the elephant in the room: vaccines. The CDC's nomination arrives smack in the middle of sustained controversy over federal vaccine guidance. The agency previously paused diagnostic testing for 27 infectious diseases and revised its COVID-19 and childhood immunization recommendations—changes that drew criticism from the American Academy of Pediatrics. Pfizer Inc. (PFE) CEO Albert Bourla publicly described Kennedy's vaccine positions as anti-science earlier this year and said progress on immunization policy required a leadership change.
So Schwartz, if she gets the job, will be walking into an agency that needs stability, a public health landscape that's politically charged, and a vaccine debate that shows no signs of cooling off. Her preventive medicine background might be exactly what some people want to see, or it might just be another data point in an ongoing argument. Either way, after months of turmoil, the CDC might finally be getting a permanent leader.
